Change control lab automation software programs were built around a simple assumption: a human edits code, the version number increments, and the change is documented before release. AI breaks that assumption. A model can be retrained on new data, updated by a vendor, or drift in its outputs without any visible version change at all. Deciding when that kind of change requires revalidation, rather than just a documentation note, is the problem this article addresses.
Quick Take:
- Traditional change control assumes deliberate, human-authored changes with clear version boundaries; AI models can change behavior through retraining, drift, or vendor updates without that clarity
- Predefined revalidation triggers, set in advance during validation planning, are the only reliable way to avoid both under-controlling AI changes and over-controlling every minor update
- Common triggers include model retraining, significant changes to input data sources, detected performance drift beyond a defined threshold, and changes to the computational environment
- FDA's Predetermined Change Control Plan (PCCP) mechanism, while built for medical devices, offers a useful model for pre-approving the scope of acceptable AI changes in any regulated setting
- Vendor-controlled AI updates create a specific compliance gap: the regulated organization remains responsible for revalidation even when it does not control the timing or content of the update
What change control means for AI systems in a regulated lab
Change control is the documented process that governs how modifications to a validated system are evaluated, approved, tested, and released. For change control lab automation software covering conventional instruments and software, the trigger is usually obvious: a vendor releases version 4.2, a configuration setting changes, a new module is installed. The change is discrete, dated, and attributable to a specific decision.
AI systems disrupt this model in three ways. First, retraining can update a model's behavior without any corresponding code change or version increment that a traditional change log would capture. Second, model drift, the gradual shift in a model's output distribution as real-world conditions diverge from training conditions, can accumulate without any single identifiable change event at all.
Third, vendor-controlled AI platforms may update models on a schedule or trigger the regulated organization does not control, sometimes without explicit notification.
The GxP framework governing AI in regulated laboratories does not exempt AI from change control obligations; it requires that the validated state of a system be maintained throughout its operational life. Effective change control lab automation software programs build their AI process around triggers that exist independently of a traditional code-level version change.
Types of AI changes and their validation implications
Not every change to an AI system carries the same weight for change control lab automation software programs. Four categories cover most of what regulated labs will encounter.
Model retraining is the most consequential category. Any update to a model's weights or parameters, whether triggered by new training data, a scheduled refresh, or a vendor-initiated retrain, is functionally a new model, even when the platform version number does not change. This category carries the highest default revalidation burden because the model's decision logic has genuinely changed.
Advanced Lab Management Certificate
The Advanced Lab Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
Configuration and parameter changes sit below retraining in typical risk. Adjusting a confidence threshold, changing which features feed into a model, or modifying how outputs are routed for human review can materially affect performance without retraining the underlying model. These changes are often the easiest to overlook because they do not feel like "model changes" even though they affect the same outputs a validation plan was built to test.
Infrastructure and platform changes are a third category specific to AI. Migrating a model to new hardware, changing the inference engine, or updating supporting libraries can shift numerical precision or latency in ways that affect output consistency, even when the model itself is untouched. This category is frequently missed because it is owned by IT rather than the model development team.
Vendor-initiated updates are the fourth category and the hardest to control directly. A SaaS-delivered AI tool may be updated by the vendor without the regulated organization initiating or scheduling the change. This does not relieve the regulated organization of its revalidation obligation under any change control lab automation software program; it just means the trigger for assessing that obligation has to come from vendor notification rather than internal initiation.
| Change type | Typical validation impact | Who usually controls it |
|---|---|---|
| Model retraining | High; functionally a new model | Internal data science team or vendor |
| Configuration or parameter change | Moderate; depends on what changed | Internal IT or quality team |
| Infrastructure or platform change | Variable; depends on numerical sensitivity | Internal IT |
| Vendor-initiated update | High; often opaque to the customer | Vendor, with customer notification |
This table is the starting point for any change control lab automation software policy covering AI: each row maps to a different default revalidation expectation, and a mature program documents that mapping explicitly rather than deciding case by case.
Interested in lab leadership?
Model retraining: when does it trigger revalidation?
Not all retraining events warrant the same response from a change control lab automation software program. The deciding factor is the magnitude and source of the change relative to what was originally validated, not simply whether retraining occurred at all.
A retraining event using a refreshed sample of data drawn from the same underlying distribution as the original training set, intended to keep the model current without changing its fundamental behavior, typically warrants focused performance verification against the original acceptance criteria rather than a full revalidation cycle under a well-designed change control lab automation software program. The question to answer is whether the retrained model still meets the thresholds established during initial validation, tested against the same held-out evaluation data used previously where possible.
A retraining event that introduces substantially different data, a new patient population, a new instrument type, a different sample matrix, or any other change that shifts the operating context the model was originally validated for, warrants a more comprehensive revalidation. In these cases, the original acceptance criteria may no longer be the right benchmark, and earlier validation lifecycle stages, including risk assessment, may need to be revisited.
A retraining event triggered by detected performance drift, rather than a scheduled refresh, should always trigger at least a documented impact assessment under any sound change control lab automation software program, regardless of how the retraining is otherwise classified. Drift-triggered retraining is evidence that the model's operating environment has changed in ways the original validation did not anticipate, which is itself a signal worth investigating beyond the immediate fix.
A risk-based decision framework for AI change control
Not every model update needs the same response. Match revalidation effort to the actual risk: document minor tweaks, verify moderate changes, and fully revalidate anything that shifts what the model was originally built to do.
GEMINI (2026)
Risk-based validation principles under CSA apply directly to change control lab automation software decisions: the depth of revalidation should scale with the risk the change poses to product quality, patient safety, and data integrity, not with the technical complexity of describing the change.
A practical framework evaluates each change against three questions. First, does the change affect a function that creates, modifies, or directly influences a record required by a predicate rule? Changes to purely advisory or non-regulated functions carry a lower default obligation.
Second, what is the magnitude of behavioral change, measured against the model's original acceptance criteria rather than against the size of the underlying code or data change? A large retraining event that produces negligible output differences may warrant less revalidation than a small configuration change that materially shifts results.
Third, was the change anticipated and pre-approved in the validation plan's change control section, or is it occurring outside any predefined framework? This third question is where FDA's Predetermined Change Control Plan (PCCP) mechanism, finalized in December 2024 for AI-enabled medical devices, offers a transferable model even outside the device context.
A PCCP allows a sponsor to pre-specify the types of model modifications anticipated, such as retraining on an expanded dataset, along with the testing protocol that will be used to verify each modification, before the modification occurs. Applying this logic to laboratory AI tools means defining, at validation time, which categories of future change are anticipated and what verification each category will require, rather than treating every future change as a novel event requiring a fresh risk assessment from scratch.
The output of this framework is a tiered response: minor changes documented without retesting, moderate changes requiring focused performance verification, and major changes requiring full or partial revalidation revisiting earlier lifecycle stages. This tiering is the heart of any workable change control lab automation software policy for AI. Building this tiering into the validation plan from the outset is far more defensible at inspection than improvising a response after a change has already occurred.
Change control SOPs for AI systems
A change control lab automation software SOP for AI systems needs to specify several elements that traditional software change control procedures typically do not address.
The SOP should define the specific triggers that initiate a change control review for AI systems: any model retraining event, any change to the input data pipeline, performance metrics falling outside predefined thresholds for a sustained period, any change to the computational environment the model runs on, and notification of a vendor-initiated update. Each trigger should map to a documented assessment step in the change control lab automation software record, not an informal judgment call made at the time.
The SOP should assign clear ownership across the functions involved in AI change management. Data science or vendor technical teams typically identify and characterize the change. Quality assurance assesses risk and determines the revalidation tier.
IT or informatics manages the technical deployment and environment documentation. Determining whether the changed function still meets the threshold for formal validation is a quality function, not a technical one, even when the underlying change originates from a technical team.
The SOP should also define documentation requirements for every change, regardless of tier, as part of a defensible change control lab automation software record. Even a change assessed as not requiring revalidation should generate a record explaining what changed, why it was assessed as low-impact, and who made that determination. This record is what demonstrates a controlled process at inspection; its absence, even for genuinely low-risk changes, is itself a finding.
When vendor model updates create compliance risk
Vendor-controlled AI introduces a structural gap that internally developed models do not create for a change control lab automation software program: the regulated organization is accountable for revalidation, but the vendor controls the timing, content, and notification of the underlying change.
This gap is best managed contractually and procedurally, not just technically. Vendor agreements for regulated AI tools should specify advance notification requirements for any model update or retraining event, access to documentation describing what changed and why, and a defined notice period before an update is applied to the production environment used for regulated work. Without these contractual provisions, a regulated lab may learn about a material model change only after it has already affected production records, at which point the change control process is reactive rather than preventive.
Labs should also build a verification step into vendor relationships: periodically confirming, through documentation review or independent testing, that the vendor's change notification practices match what was contracted. A vendor that cannot reliably notify customers of model updates is not equipped to support a GxP-regulated customer running a serious change control lab automation software program, regardless of how capable its underlying AI technology is.
Change control lab automation software: building a process that holds up
Change control lab automation software programs that work for AI need predefined triggers, not after-the-fact judgment calls: model retraining, significant data source changes, detected drift, infrastructure changes, and vendor updates should each map to a documented assessment step defined in advance. The revalidation tier, whether documentation only, focused verification, or full revalidation, should be determined by the magnitude of behavioral change against original acceptance criteria, not by the apparent size of the underlying technical change. Labs that build this framework into their validation plans from the start, rather than improvising a response to each new AI update, will manage genuine risk without grinding routine operations to a halt every time a model is refreshed.
This content includes text that has been generated with the assistance of AI. For more information, view Lab Manager's AI use policy.
References
International Society for Pharmaceutical Engineering. GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems, Second Edition (includes Appendix D11 on AI/ML). ISPE, 2022. Available at: https://ispe.org/publications/guidance-documents/gamp-5-guide-2nd-edition
U.S. Food and Drug Administration. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions. December 4, 2024. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence
U.S. Code of Federal Regulations. 21 CFR Part 820 — Quality Management System Regulation. Available at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820
